Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
01.18.22
OpGen to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022
01.10.22
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business Update
12.14.21
OpGen subsidiary Ares Genetics announces the strategic expansion of ARESdb proprietary contents

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events